Protalix BioTherapeutics
PLX
#8895
Rank
NZ$0.24 B
Marketcap
NZ$3.05
Share price
2.02%
Change (1 day)
-0.50%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): NZ$12.95 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$61.84 Million. In 2024 the company made an earning of NZ$9 Million a decrease over its 2023 earnings that were of NZ$20.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$12.95 M43.94%
2024 NZ$9 M-55.62%
2023 NZ$20.28 M-199.05%
2022 -NZ$20.48 Million-40.38%
2021 -NZ$34.35 Million-732.31%
2020 NZ$5.43 M-130.53%
2019 -NZ$17.8 Million189.85%
2018 -NZ$6.14 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$31.95 Million-32.37%
2015 -NZ$47.24 Million10.11%
2014 -NZ$42.9 Million-7.59%
2013 -NZ$46.42 Million
2011 -NZ$53.76 Million-19.39%
2010 -NZ$66.69 Million20.87%
2009 -NZ$55.17 Million32.26%
2008 -NZ$41.71 Million-5.46%
2007 -NZ$44.12 Million
2004 -NZ$0.29 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.29 Million-57.03%
2001 -NZ$0.67 Million1.03%
2000 -NZ$0.66 Million-53.22%
1999 -NZ$1.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
NZ$8.59 M-33.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.00 B 7,718.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.45 B 158,795.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.05 B 23,656.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel